Blast Crisis: Clinical Trials

22 trials for Blast Crisis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed. 22 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 322Completed 22
Phase 22Completed 2

Follow Blast Crisis: new trials by email Literature Review of Blast Crisis trials Research Report on Blast Crisis

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Eltrombopag Olamine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Phase 2 / Phase 3CompletedM.D. Anderson Cancer Center212012-01-132023-09-26
American Ginseng in Treating Patients With Fatigue Caused by Cancer
American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedAlliance for Clinical Trials in Oncology3642008-10-012017-02-09
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
cyclosporine ophthalmic emulsion, placebo - Chronic Myeloproliferative Disorders, Graft Versus Host Disease
Phase 3CompletedVanderbilt-Ingram Cancer Center1642008-10-012017-03-07
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
educational intervention, informational intervention, internet-based intervention - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedTufts Medical Center1982008-06-012011-07-13
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedCase Comprehensive Cancer Center5832008-04-012020-07-27
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedVanderbilt-Ingram Cancer Center982005-05-012012-09-06
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
graft versus host disease prophylaxis/therapy, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation - Graft Versus Host Disease, Leukemia
Phase 3CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins722002-12-012014-04-17
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
acyclovir, acyclovir sodium, valacyclovir - Cancer
Phase 3CompletedFred Hutchinson Cancer Center2002-04-012010-09-21
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedAlliance for Clinical Trials in Oncology1002000-10-012016-07-06
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
caspofungin acetate, liposomal amphotericin B - Cancer
Phase 3CompletedMemorial Sloan Kettering Cancer Center2000-08-012013-01-18
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Fragmin, placebo - Cervical Cancer, Chronic Myeloproliferative Disorders
Phase 3CompletedJonsson Comprehensive Cancer Center2000-04-012020-08-03
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
St. John's wort - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedMemorial Sloan Kettering Cancer Center1999-12-012013-01-18
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
captopril, cyclophosphamide, autologous bone marrow transplantation - Cancer
Phase 3CompletedNorthwestern University351999-10-012012-06-06
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
liposomal amphotericin B - Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC1151999-06-012012-09-24
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
palivizumab, ribavirin - Cancer
Phase 3CompletedFred Hutchinson Cancer Center1999-02-012010-04-02
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
anti-thymocyte globulin, busulfan, carboplatin - Chronic Myeloproliferative Disorders, Leukemia
Phase 2 / Phase 3CompletedRoswell Park Cancer Institute3611998-10-192021-08-13
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
fluconazole, itraconazole - Cancer
Phase 3CompletedFred Hutchinson Cancer Center5781998-10-012010-04-02
Treatment for Chronic Pain in Patients With Advanced Cancer
dextromethorphan hydrobromide, morphine sulfate - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedNCIC Clinical Trials Group871998-06-112020-04-03

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Leukemia, Myeloid, Accelerated Phase (21)  ·  Leukemia, Myeloid, Chronic-Phase (21)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (21)  ·  Burkitt Lymphoma (20)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (19)  ·  Lymphoma, B-Cell, Marginal Zone (19)  ·  Lymphoma, Follicular (19)  ·  Lymphoma, Large B-Cell, Diffuse (19)  ·  Lymphoma, Large-Cell, Immunoblastic (19)  ·  Lymphoma, Mantle-Cell (19)  ·  Lymphoma, Non-Hodgkin (19)  ·  Primary Myelofibrosis (19)  ·  Hodgkin Disease (18)  ·  Leukemia, Myeloid, Acute (18)

Broader conditions

Bone Marrow Diseases (22)  ·  Carcinogenesis (22)  ·  Cell Transformation, Neoplastic (22)  ·  Chronic Disease (22)  ·  Disease Attributes (22)  ·  Hematologic Diseases (22)  ·  Hemic and Lymphatic Diseases (22)  ·  Leukemia, Myeloid (22)  ·  Neoplasms by Histologic Type (22)  ·  Neoplastic Processes (22)  ·  Pathologic Processes (22)  ·  Pathological Conditions, Signs and Symptoms (22)  ·  Immune System Diseases (21)  ·  Immunoproliferative Disorders (21)  ·  Leukemia, Lymphoid (21)

Interventions

Cyclophosphamide (3)  ·  Early Intervention, Educational (3)  ·  Etoposide (2)  ·  Psychiatric Rehabilitation (2)  ·  Radiotherapy (2)  ·  Therapeutics (2)  ·  liposomal amphotericin B (2)  ·  Acyclovir (1)  ·  Antilymphocyte Serum (1)  ·  Asian ginseng (1)  ·  Busulfan (1)  ·  Captopril (1)  ·  Carboplatin (1)  ·  Carmustine (1)  ·  Caspofungin (1)

Sponsors

Fred Hutchinson Cancer Center (3)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  Alliance for Clinical Trials in Oncology (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Vanderbilt-Ingram Cancer Center (2)  ·  Case Comprehensive Cancer Center (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  INSYS Therapeutics Inc (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  NCIC Clinical Trials Group (1)  ·  Northwestern University (1)  ·  Roswell Park Cancer Institute (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  Tufts Medical Center (1)

Countries

United States (20)  ·  Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Israel (2)  ·  Slovakia (2)  ·  Turkey (Türkiye) (2)  ·  Finland (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Portugal (1)

Top investigators

David J. Straus, MD (1)  ·  Debra Barton, RN, PhD, AOCN, FAAN (1)  ·  Eduardo Bruera, MD (1)  ·  Garrett Nichols, MD, MSC (1)  ·  Gautam Borthakur (1)  ·  John A. Glaspy, MD, MPH (1)  ·  Karen Syrjala (1)  ·  Kent Sepkowitz, MD (1)  ·  Kieren A. Marr, MD (1)  ·  Larry Dillaha, MD (1)  ·  Leo I. Gordon, MD (1)  ·  Madan Jagasia, MD (1)  ·  Michael Boeckh, MD (1)  ·  Michel P. Glauser, MD (1)  ·  Nancy Wells, DNSc, RN (1)

Results publications

PMID 15459300, PMID 17397698, PMID 22157574, PMID 22480131, PMID 26700120, PMID 26700123, PMID 27020837, PMID 32628342, PMID 33420905, PMID 36282798, PMID 36999619

NIH funding

P30CA068485 (2), P01CA015396 (1), P30CA006973 (1), P30CA008748 (1), R01CA112631 (1), R01CA119196 (1), R01CA127655 (1)